Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrain

MR Imaging Features of Amyloid-Related Imaging Abnormalities

J. Barakos, R. Sperling, S. Salloway, C. Jack, A. Gass, J.B. Fiebach, D. Tampieri, D. Melançon, Y. Miaux, G. Rippon, R. Black, Y. Lu, H.R. Brashear, H.M. Arrighi, K.A. Morris and M. Grundman
American Journal of Neuroradiology October 2013, 34 (10) 1958-1965; DOI: https://doi.org/10.3174/ajnr.A3500
J. Barakos
aFrom the California Pacific Medical Center (J.B.), San Francisco, California
bSynarc (J.B., Y.M.), Newark, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Sperling
cBrigham and Women's Hospital (R.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Salloway
dWarren Alpert Medical School of Brown University (S.S.), Providence, Rhode Island
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Jack
eMayo Clinic (C.J.), Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Gass
fUniversity Hospital Mannheim (A.G.), University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.B. Fiebach
gCenter for Stroke Research (J.B.F.), Charité, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Tampieri
hNeuroRx Research (D.T., D.M.), Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Melançon
hNeuroRx Research (D.T., D.M.), Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Miaux
bSynarc (J.B., Y.M.), Newark, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Rippon
iPfizer Inc (G.R., R.B.), Collegeville, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Black
iPfizer Inc (G.R., R.B.), Collegeville, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Lu
aFrom the California Pacific Medical Center (J.B.), San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.R. Brashear
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.M. Arrighi
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.A. Morris
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Grundman
jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
kGlobal Partners Inc (M.G.), Cambridge, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Information

vol. 34 no. 10 1958-1965
DOI 
https://doi.org/10.3174/ajnr.A3500
PubMed 
23578674

Published By 
American Journal of Neuroradiology
Print ISSN 
0195-6108
Online ISSN 
1936-959X
History 
  • Received August 9, 2012
  • Accepted after revision December 2, 2012
  • Published online October 8, 2013.

Article Versions

  • Latest version (April 11, 2013 - 08:14).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2013 by American Journal of Neuroradiology

Author Information

  1. J. Barakosa,b,
  2. R. Sperlingc,
  3. S. Sallowayd,
  4. C. Jacke,
  5. A. Gassf,
  6. J.B. Fiebachg,
  7. D. Tampierih,
  8. D. Melançonh,
  9. Y. Miauxb,
  10. G. Ripponi,
  11. R. Blacki,
  12. Y. Lua,
  13. H.R. Brashearj,
  14. H.M. Arrighij,
  15. K.A. Morrisj and
  16. M. Grundmanj,k
  1. aFrom the California Pacific Medical Center (J.B.), San Francisco, California
  2. bSynarc (J.B., Y.M.), Newark, California
  3. cBrigham and Women's Hospital (R.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
  4. dWarren Alpert Medical School of Brown University (S.S.), Providence, Rhode Island
  5. eMayo Clinic (C.J.), Rochester, Minnesota
  6. fUniversity Hospital Mannheim (A.G.), University of Heidelberg, Mannheim, Germany
  7. gCenter for Stroke Research (J.B.F.), Charité, Berlin, Germany
  8. hNeuroRx Research (D.T., D.M.), Montreal, Quebec, Canada
  9. iPfizer Inc (G.R., R.B.), Collegeville, Pennsylvania
  10. jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
  11. kGlobal Partners Inc (M.G.), Cambridge, Massachusetts.
  1. Please address correspondence to Jerome Barakos, MD, California Pacific Medical Center, 2333 Buchanan St, San Francisco, CA 94115; e-mail: barakosmd{at}gmail.com
View Full Text

Altmetrics

Cited By...

  • 70 Citations
  • 86 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
    Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H. Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling, John O’Gorman, Fang Qian, Mahin Arastu, Mingwei Li, Sowmya Chollate, Melanie S. Brennan, Omar Quintero-Monzon, Robert H. Scannevin, H. Moore Arnold, Thomas Engber, Kenneth Rhodes, James Ferrero, Yaming Hang, Alvydas Mikulskis, Jan Grimm, Christoph Hock, Roger M. Nitsch, Alfred Sandrock
    Nature 2016 537 7618
  • Donanemab in Early Symptomatic Alzheimer Disease
    John R. Sims, Jennifer A. Zimmer, Cynthia D. Evans, Ming Lu, Paul Ardayfio, JonDavid Sparks, Alette M. Wessels, Sergey Shcherbinin, Hong Wang, Emel Serap Monkul Nery, Emily C. Collins, Paul Solomon, Stephen Salloway, Liana G. Apostolova, Oskar Hansson, Craig Ritchie, Dawn A. Brooks, Mark Mintun, Daniel M. Skovronsky, Rafael Abreu, Pinky Agarwal, Puja Aggarwal, Marc Agronin, Alison Allen, Dario Altamirano, Gustavo Alva, James Andersen, Allan Anderson, Donald Anderson, Jennifer Arnold, Takashi Asada, Yasuhiro Aso, Vikram Atit, Ricardo Ayala, Michael Badruddoja, Hanna Badzio-jagiello, Michal Bajacek, David Barton, David Bear, Sabrina Benjamin, Richard Bergeron, Perminder Bhatia, Sandra Black, Allan Block, Mohammad Bolouri, Wendy Bond, Jean Bouthillier, Sharon Brangman, Bruce Brew, Sarah Brisbin, Toby Brisken, Amy Brodtmann, Mark Brody, Jared Brosch, Celia Brown, Paul Brownstone, Sylwia Bukowczan, Jeffrey Burns, Alicia Cabrera, Horace Capote, Angel Carrasco, Jose Cevallos Yepez, Eric Chavez, Howard Chertkow, Urszula Chyrchel-paszkiewicz, Anthony Ciabarra, Edward Clemmons, Daniel Cohen, Robert Cohen, Ian Cohen, Mauricio Concha, Brian Costell, Denis Crimmins, Yvette Cruz-pagan, Adolfo Cueli, Robert Cupelo, Maciej Czarnecki, David Darby, P.l.j. Dautzenberg, Peter De Deyn, Jose De La Gandara, Kenneth Deck, David Dibenedetto, Mark Dibuono, Eric Dinnerstein, Ahmet Dirican, Shanker Dixit, Jacek Dobryniewski, Ryan Drake, Peter Drysdale, Ranjan Duara, John Duffy, Aaron Ellenbogen, Victor Faradji, Marc Feinberg, Robert Feldman, Simon Fishman, Stephen Flitman, Concetta Forchetti, Ivonne Fraga, Andrew Frank, Benjamin Frishberg, Hiroto Fujigasaki, Hiroyuki Fukase, Ileana Fumero, Kenichi Furihata, Christopher Galloway, Rekha Gandhi, Kristi George, Marcel Germain, Darren Gitelman, Nicholas Goetsch, Danielle Goldfarb, Mark Goldstein, Lawrence Goldstick, Yaneicy Gonzalez Rojas, Ira Goodman, David Greeley, Carl Griffin, Eric Grigsby, Daniel Grosz, Karl Hafner, David Hart, Sam Henein, Brad Herskowitz, Shinji Higashi, Yasuto Higashi, Gilbert Ho, Jonathan Hodgson, Mark Hohenberg, Larry Hollenbeck, Richard Holub, Tomokatsu Hori, Jakub Hort, Jan Ilkowski, K. Jennifer Ingram, Mitchell Isaac, Mitsunori Ishikawa, Lubos Janu, Mark Johnston, William Julio, William Justiz, Tomotsugu Kaga, Tatsuya Kakigi, Marvin Kalafer, Mikiko Kamijo, Jeffrey Kaplan, Michael Karathanos, Sadao Katayama, Siddharth Kaul, Andrew Keegan, Diana Kerwin, Uzma Khan, Arifulla Khan, Noriyuki Kimura, Gregory Kirk, Gabriela Klodowska, Hisatomo Kowa, Christen Kutz, Joseph Kwentus, Rosalyn Lai, Ayesha Lall, Mary Lawrence, Elly Lee, Ramon Leon, Gary Linker, Pawel Lisewski, Jonathan Liss, Collins Liu, Scott Losk, Ewelina Lukaszyk, Jennifer Lynch, Stephen Macfarlane, Josephine Macsweeney, Nicholas Mannering, Oto Markovic, Donald Marks, Joseph Masdeu, Yutaka Matsui, Kunitaka Matsuishi, Peter Mcallister, Brock Mcconnehey, Alvin Mcelveen, Lora Mcgill, Adam Mecca, Michael Mega, Jason Mensah, Anatol Mickielewicz, Artin Minaeian, Bharat Mocherla, Cynthia Murphy, Paul Murphy, Hirotaka Nagashima, Anil Nair, Malini Nair, John Nardandrea, Marshall Nash, Ziad Nasreddine, Yoshihiko Nishida, Jeffrey Norton, Lazaro Nunez, Jun Ochiai, Takuya Ohkubo, Yasuyuki Okamura, Eugene Okorie, Esteban Olivera, John O'mahony, Omid Omidvar, Desiree Ortiz-Cruz, Alexander Osowa, Michelle Papka, Alicia Parker, Paayal Patel, Ashok Patel, Meenakshi Patel, Claude Patry, Elizabeth Peckham, Michael Pfeffer, Alison Pietras, Michael Plopper, Anton Porsteinsson, Raphael Poulin Robitaille, Niels Prins, Orlando Puente, Marcin Ratajczak, Margaret Rhee, Angela Ritter, Ramon Rodriguez, Lilia Rodriguez Ables, Julio Rojas, Jeffrey Ross, Paule Royer, Jay Rubin, David Russell, Sterre Malou Rutgers, Stephanie Rutrick, Martin Sadowski, Beth Safirstein, Takafumi Sagisaka, Douglas Scharre, Lon Schneider, Curtis Schreiber, Michael Schrift, Paul Schulz, Harvey Schwartz, Julie Schwartzbard, John Scott, Lissette Selem, Pramod Sethi, Sharon Sha, Kenneth Sharlin, Sanjiv Sharma, Thomas Shiovitz, Rajinder Shiwach, Martin Sladek, Bart Sloan, Amanda Smith, Paul Solomon, Ehab Sorial, Evelio Sosa, Mary Stedman, Susan Steen, Lee Stein, Arkadiy Stolyar, John Stoukides, Shinji Sudoh, James Sutton, Junaid Syed, Kinga Szigeti, Hisatsugu Tachibana, Yuichi Takahashi, Amane Tateno, James Dale Taylor, Kelly Taylor, Oleg Tcheremissine, Adly Thebaud, Stephen Thein, Louise Thurman, Steven Toenjes, Hiromasa Toji, Misaki Toma, Duc Tran, Pilar Trueba, Masashi Tsujimoto, Raymond Turner, Akiyoshi Uchiyama, Dorota Ussorowska, Sanjeev Vaishnavi, Elena Valor, Joel Vandersluis, Alberto Vasquez, Juan Velez, Cherian Verghese, Klaudia Vodickova-borzova, David Watson, David Weidman, David Weisman, Alexander White, Katherine Willingham, Izabela Winkel, Paul Winner, Jaron Winston, Adam Wolff, Hideo Yagi, Hideki Yamamoto, Sanjay Yathiraj, Yasumasa Yoshiyama, Marzena Zboch
    JAMA 2023 330 6
  • Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
    Stephen Salloway, Spyros Chalkias, Frederik Barkhof, Patrick Burkett, Jerome Barakos, Derk Purcell, Joyce Suhy, Fiona Forrestal, Ying Tian, Kimberly Umans, Guanfang Wang, Priya Singhal, Samantha Budd Haeberlein, Karen Smirnakis
    JAMA Neurology 2022 79 1
  • Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
    Harald Hampel, Aya Elhage, Min Cho, Liana G Apostolova, James A R Nicoll, Alireza Atri
    Brain 2023 146 11
  • Anti-amyloid antibody therapies in Alzheimer’s disease
    Robert Perneczky, Frank Jessen, Timo Grimmer, Johannes Levin, Agnes Flöel, Oliver Peters, Lutz Froelich
    Brain 2023 146 3
  • Amyloid-Related Imaging Abnormalities and β-Amyloid–Targeting Antibodies
    Massimo Filippi, Giordano Cecchetti, Edoardo Gioele Spinelli, Paolo Vezzulli, Andrea Falini, Federica Agosta
    JAMA Neurology 2022 79 3
  • Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
    Charles G. Withington, R. Scott Turner
    Frontiers in Neurology 2022 13
  • Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
    Ana-María Lacosta, María Pascual-Lucas, Pedro Pesini, Diego Casabona, Virginia Pérez-Grijalba, Iván Marcos-Campos, Leticia Sarasa, Jesus Canudas, Hassnae Badi, Inmaculada Monleón, Itziar San-José, Josep Munuera, Octavio Rodríguez-Gómez, Carla Abdelnour, Asunción Lafuente, Mar Buendía, Mercè Boada, Lluis Tárraga, Agustín Ruiz, Manuel Sarasa
    Alzheimer's Research & Therapy 2018 10 1
  • Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice
    P.M. Cogswell, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.R. Jack, T.Y. Poussaint, C.A. Raji, V.K. Ramanan, C.T. Whitlow
    American Journal of Neuroradiology 2022 43 9
  • Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives
    Mina Park, Won-Jin Moon
    Korean Journal of Radiology 2016 17 6
  • Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
    Jacopo C. DiFrancesco, Martina Longoni, Fabrizio Piazza
    Frontiers in Neurology 2015 6
  • Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease
    Natalie S. Ryan, Geert-Jan Biessels, Lois Kim, Jennifer M. Nicholas, Philip A. Barber, Phoebe Walsh, Priya Gami, Huw R. Morris, António J. Bastos-Leite, Jonathan M. Schott, Jon Beck, Simon Mead, Lucia Chavez-Gutierrez, Bart de Strooper, Martin N. Rossor, Tamas Revesz, Tammaryn Lashley, Nick C. Fox
    Neurobiology of Aging 2015 36 12
  • Amyloid-Related Imaging Abnormalities: An Update
    Michelle Roytman, Faizullah Mashriqi, Khaled Al-Tawil, Paul E. Schulz, Greg Zaharchuk, Tammie L. S. Benzinger, Ana M. Franceschi
    American Journal of Roentgenology 2023 220 4
  • Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy
    Jerome Barakos, D. Purcell, J. Suhy, S. Chalkias, P. Burkett, C. Marsica Grassi, C. Castrillo-Viguera, I. Rubino, E. Vijverberg
    The Journal of Prevention of Alzheimer's Disease 2022 9 2
  • Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
    Nzeera Ketter, H. Robert Brashear, Jennifer Bogert, Jianing Di, Yves Miaux, Achim Gass, Derk D. Purcell, Frederik Barkhof, H. Michael Arrighi
    Journal of Alzheimer's Disease 2017 57 2
  • Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer’s Disease: Need for Prognostic Biomarkers?
    Fabrizio Piazza, Bengt Winblad
    Journal of Alzheimer's Disease 2016 52 2
  • Amyloid-related Imaging Abnormalities in Alzheimer Disease Treated with Anti–Amyloid-β Therapy
    Amit Agarwal, Vivek Gupta, Pavan Brahmbhatt, Amit Desai, Prasanna Vibhute, Nelly Joseph-Mathurin, Girish Bathla
    RadioGraphics 2023 43 9
  • Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects
    David A. Loeffler
    Journal of Alzheimer's Disease Reports 2023 7 1
  • Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications
    Sarah J. Doran, Russell P. Sawyer
    Frontiers in Neuroscience 2024 18
  • Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
    Hyomin Jeong, Heewon Shin, Seungpyo Hong, YoungSoo Kim
    Experimental Neurobiology 2022 31 2
  • Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies
    H. Robert Brashear, Nzeera Ketter, Jennifer Bogert, Jianing Di, Stephen P. Salloway, Reisa Sperling, Katherine Bangen
    Journal of Alzheimer's Disease 2018 66 4
  • Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer’s disease brains
    Clémence Dudeffant, Matthias Vandesquille, Kelly Herbert, Clément M. Garin, Sandro Alves, Véronique Blanchard, Emmanuel E. Comoy, Fanny Petit, Marc Dhenain
    Scientific Reports 2017 7 1
  • Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field
    Sara Shams, Lars-Olof Wahlund
    Biomarkers in Medicine 2016 10 1
  • Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti–β-Amyloid Immunotherapy
    So Yeong Jeong, Chong Hyun Suh, Woo Hyun Shim, Jae-Sung Lim, Jae-Hong Lee, Sang Joon Kim
    Neurology 2022 99 19
  • Cerebral Superficial Siderosis
    Stefan Weidauer, Elisabeth Neuhaus, Elke Hattingen
    Clinical Neuroradiology 2023 33 2
  • Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis
    Angelika Alonso, Philipp Eisele, Anne D. Ebert, Martin Griebe, Britta Engelhardt, Kristina Szabo, Michael G. Hennerici, Achim Gass
    Neurology Neuroimmunology & Neuroinflammation 2015 2 6
  • Anti-Aβ single-chain variable fragment antibodies exert synergistic neuroprotective activities inDrosophilamodels of Alzheimer's disease
    Pedro Fernandez-Funez, Yan Zhang, Jonatan Sanchez-Garcia, Lorena de Mena, Swati Khare, Todd E. Golde, Yona Levites, Diego E. Rincon-Limas
    Human Molecular Genetics 2015 24 21
  • Tumefactive Primary Central Nervous System Vasculitis: Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease
    S. Suthiphosuwan, A. Bharatha, C.C.-T. Hsu, A.W. Lin, J.A. Maloney, D.G. Munoz, C.A. Palmer, A.G. Osborn
    American Journal of Neuroradiology 2020 41 11
  • Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
    Petrice M. Cogswell, Trevor J. Andrews, Jerome A. Barakos, Frederik Barkhof, Suzie Bash, Marc Daniel Benayoun, Gloria C. Chiang, Ana M. Franceschi, Clifford R. Jack, Jay J. Pillai, Tina Young Poussaint, Cyrus A. Raji, Vijay K. Ramanan, Jody Tanabe, Lawrence Tanenbaum, Christopher T. Whitlow, Fang F. Yu, Greg Zaharchuk, Michael Zeinah, Tammie S. Benzinger
    American Journal of Neuroradiology 2025 46 1
  • Anti-Aβ single-chain variable fragment antibodies restore memory acquisition in a Drosophila model of Alzheimer’s disease
    Alfonso Martin-Peña, Diego E. Rincon-Limas, Pedro Fernandez-Funez
    Scientific Reports 2017 7 1
  • Artificial Intelligence Assistive Software Tool for Automated Detection and Quantification of Amyloid-Related Imaging Abnormalities
    Diana M. Sima, Thanh Vân Phan, Simon Van Eyndhoven, Sophie Vercruyssen, Ricardo Magalhães, Arno Liseune, Arne Brys, Peter Frenyo, Vasilis Terzopoulos, Celine Maes, Joshua Guo, Richard Hughes, Refaat E. Gabr, Willem Huijbers, Paramita Saha-Chaudhuri, Gioacchino G. Curiale, Andrew Becker, Shibeshih Belachew, Wim Van Hecke, Annemie Ribbens, Dirk Smeets
    JAMA Network Open 2024 7 2
  • A combined physiologically‐based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease
    Hugo Geerts, Mike Walker, Rachel Rose, Silke Bergeler, Piet H. van der Graaf, Edgar Schuck, Akihiko Koyama, Sanae Yasuda, Ziad Hussein, Larisa Reyderman, Chad Swanson, Antonio Cabal
    CPT: Pharmacometrics & Systems Pharmacology 2023 12 4
  • Alzheimer's disease clinical trials: past failures and future opportunities
    Roy Yaari, Ann Hake
    Clinical Investigation 2015 5 3
  • Histopathological correlates of haemorrhagic lesions on ex vivo magnetic resonance imaging in immunized Alzheimer’s disease cases
    Ashley A. Scherlek, Mariel G. Kozberg, James A. R. Nicoll, Valentina Perosa, Whitney M. Freeze, Louise van der Weerd, Brian J. Bacskai, Steven M. Greenberg, Matthew P. Frosch, Delphine Boche, Susanne J. van Veluw
    Brain Communications 2022 4 1
  • Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization
    Hans Urban, Eike Steidl, Elke Hattingen, Katharina Filipski, Markus Meissner, Martin Sebastian, Agnes Koch, Adam Strzelczyk, Marie-Thérèse Forster, Peter Baumgarten, Michael W. Ronellenfitsch, Joachim P. Steinbach, Martin Voss
    Frontiers in Immunology 2022 12
  • Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy‐related inflammation: A systematic analysis of published and seven new cases
    Levente Szalardy, Bernadett Fakan, Rita Maszlag‐Torok, Emil Ferencz, Zita Reisz, Bence L. Radics, Sandor Csizmadia, Laszlo Szpisjak, Adam Annus, Denes Zadori, Gabor G. Kovacs, Peter Klivenyi
    Neuropathology and Applied Neurobiology 2024 50 1
  • Dural and Leptomeningeal Diseases: Anatomy, Causes, and Neuroimaging Findings
    Ryo Kurokawa, Mariko Kurokawa, Saiko Isshiki, Taisuke Harada, Moto Nakaya, Akira Baba, Shotaro Naganawa, John Kim, Jayapalli Bapuraj, Ashok Srinivasan, Osamu Abe, Toshio Moritani
    RadioGraphics 2023 43 9
  • Amyloid-Related Imaging Abnormalities in the Era of Anti-Amyloid Beta Monoclonal Antibodies for Alzheimer’s Disease: Recent Updates on Clinical and Imaging Features and MRI Monitoring
    So Yeong Jeong, Chong Hyun Suh, Sang Joon Kim, Cynthia Ann Lemere, Jae-Sung Lim, Jae-Hong Lee
    Korean Journal of Radiology 2024 25 8
  • Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial
    Shoichiro Sato, Naohisa Hatakeyama, Shinji Fujikoshi, Sadao Katayama, Hideaki Katagiri, John R. Sims
    Neurology and Therapy 2024 13 3
  • Validation of an MRI Rating Scale for Amyloid‐Related Imaging Abnormalities
    Arianne Bechten, Mike P. Wattjes, Derk D. Purcell, Esther Sanchez Aliaga, Marita Daams, H. Robert Brashear, H. Michael Arrighi, Frederik Barkhof
    Journal of Neuroimaging 2017 27 3
  • Lecanemab: Appropriate Use Recommendations by Korean Dementia Association
    Kee Hyung Park, Geon Ha Kim, Chi-Hun Kim, Seong-Ho Koh, So Young Moon, Young Ho Park, Sang Won Seo, Bora Yoon, Jae-Sung Lim, Byeong C. Kim, Hee-Jin Kim, Hae Ri Na, YongSoo Shim, YoungSoon Yang, Chan-Nyoung Lee, Hak Young Rhee, San Jung, Jee Hyang Jeong, Hojin Choi, Dong Won Yang, Seong Hye Choi
    Dementia and Neurocognitive Disorders 2024 23 4
  • Ischemic stroke associated with amyloid‐related imaging abnormalities in a patient treated with lecanemab
    Alec W. Gibson, Holly Elser, Michela Rosso, Eli J. Cornblath, Yombe Fonkeu, Sashank Prasad, Aaron Rothstein, Ilya M. Nasrallah, David A. Wolk, Michael H. Guo
    Alzheimer's & Dementia 2024 20 11
  • Neuroimaging of therapy-associated brain tissue abnormalities
    Jennifer Linn
    Current Opinion in Neurology 2014 27 4
  • Statistical Parametric Mapping in Amyloid Positron Emission Tomography
    Natasha M. Smith, Jeremy N. Ford, Arsalan Haghdel, Lidia Glodzik, Yi Li, Debra D’Angelo, Arindam RoyChoudhury, Xiuyuan Wang, Kaj Blennow, Mony J. de Leon, Jana Ivanidze
    Frontiers in Aging Neuroscience 2022 14
  • Advancements in Pharmacological Treatment of Alzheimer’s Disease: The Advent of Disease-Modifying Therapies (DMTs)
    Qiong Wang, Sihui Chen, Junhui Wang, Huifang Shang, Xueping Chen
    Brain Sciences 2024 14 10
  • Cerebral amyloid angiopathy and the immune system
    Danielle Munsterman, Sarina Falcione, Rebecca Long, Roobina Boghozian, Twinkle Joy, Richard Camicioli, Eric E. Smith, Glen C. Jickling
    Alzheimer's & Dementia 2024 20 7
  • Disease Modifying Monoclonal Antibodies and Symptomatic Pharmacological Treatment for Alzheimer’s Disease
    Xiaoming Qi, Damir Nizamutdinov, Song Stephen Yi, Erxi Wu, Jason H. Huang
    Biomedicines 2024 12 11
  • Imaging of Amyloid-Related Imaging Abnormalities (ARIA)
    Horst Urbach, Jennifer Linn, Elke Hattingen, Jochen Fiebach
    RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2024 196 04
  • Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases
    Md Shamim Rahman, Rabia Islam, Mohammad Iqbal H. Bhuiyan
    Frontiers in Pharmacology 2024 15
  • Subcortical signal alteration of corticospinal tracts. A radiologic manifestation of ARIA: A case report
    Houman Sotoudeh, Mohammadreza Alizadeh, Ramin Shahidi, Parnian Shobeiri, Natelson love, Aparna Singhal
    Radiology Case Reports 2023 18 1
  • Clinical Management in Alzheimer’s Disease in the Era of Disease-Modifying Therapies
    Michael H. Guo, Sanjeev N. Vaishnavi
    Current Treatment Options in Neurology 2023 25 5
  • Clinical Neuroradiology
    Claudia Godi, Andrea Falini
    2019
  • Anti-Amyloid Therapies for Alzheimer’s Disease and Amyloid-Related Imaging Abnormalities: Implications for the Emergency Medicine Clinician
    Megan A. Rech, Christopher R. Carpenter, Neelum T. Aggarwal, Ula Hwang
    Annals of Emergency Medicine 2025 85 6
  • Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy
    Houman Sotoudeh, Mohammadreza Alizadeh, Ramin Shahidi, Parnian Shobeiri, Zahra Saadatpour, C. Austin Wheeler, Marissa Natelson Love, Manoj Tanwar
    Frontiers in Radiology 2024 3
  • Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy
    Marialuisa Zedde, Ilaria Grisendi, Federica Assenza, Manuela Napoli, Claudio Moratti, Claudio Pavone, Lara Bonacini, Giovanna Di Cecco, Serena D’Aniello, Francesca Romana Pezzella, Giovanni Merlino, Fabrizio Piazza, Alessandro Pezzini, Andrea Morotti, Enrico Fainardi, Danilo Toni, Franco Valzania, Rosario Pascarella
    Journal of Clinical Medicine 2024 13 15
  • Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
    So Yeong Jeong, Chong Hyun Suh, Jae-Sung Lim, Yangsean Choi, Ho Sung Kim, Sang Joon Kim, Jae-Hong Lee
    Journal of the Korean Society of Radiology 2025 86 1
  • Enhanced Reader Confidence and Differentiation of Calcification from Cerebral Microbleed Diagnosis Using QSM Relative to SWI
    Chris Kang, Pritesh Mehta, Yi S. Chang, Rafeeque A. Bhadelia, Rafael Rojas, Max Wintermark, Jalal B. Andre, Ethan Yang, Magdy Selim, Ajith J. Thomas, Aristotelis Filippidis, Yan Wen, Pascal Spincemaille, Nils D. Forkert, Yi Wang, Salil Soman
    Clinical Neuroradiology 2024
  • Practical Brain MRI Guidelines for Anti-Aβ Antibody Treatment in Early Symptomatic Alzheimer’s Disease
    Shingo Kakeda, Yukio Miki, Kohsuke Kudo, Harushi Mori, Aya M. Tokumaru, Osamu Abe, Shigeki Aoki
    Magnetic Resonance in Medical Sciences 2025
  • Practical brain MRI guidelines for anti-Aβ antibody treatment in early symptomatic Alzheimer’s disease
    Shingo Kakeda, Yukio Miki, Kohsuke Kudo, Harushi Mori, Aya M. Tokumaru, Osamu Abe, Shigeki Aoki
    Japanese Journal of Radiology 2025
  • Radiopaedia.org
    Frank Gaillard, Rohit Sharma, Chesterlee Ocampo
    2014
  • Radiopaedia.org
    Frank Gaillard, Arlene Campos, Rohit Sharma
    2021
  • The global research of magnetic resonance imaging in Alzheimer’s disease: a bibliometric analysis from 2004 to 2023
    Xiaoyu Sun, Jianghua Zhu, Ruowei Li, Yun Peng, Lianggeng Gong
    Frontiers in Neurology 2025 15
  • Altered Clearance and Amyloid-Related Imaging Abnormalities
    Petrice M. Cogswell, Brian J. Burkett, Derek R. Johnson, Jay J. Pillai
    Neuroimaging Clinics of North America 2025 35 2
  • Alzheimer's Disease Clinical Trials: What Have We Learned From Magnetic Resonance Imaging
    Samantha By, Anja Kahl, Petrice M. Cogswell
    Journal of Magnetic Resonance Imaging 2025 61 2
  • Amyloid related imaging abnormalities in the emergency setting
    Jan Czerminski, Supriya Khatri, Balaji Rao
    Emergency Radiology 2024 31 6
  • Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
    Jimin Kim, Eunhee Kim, Mina Park, Yun Jung Bae, Chong Hyun Suh, Sung-Hye You, Younghee Yim, Ho-Joon Lee, Jin Wook Choi, Se Won Oh, Won-Jin Moon
    Journal of the Korean Society of Radiology 2025 86 1
  • Amyloid‐Related Imaging Abnormality (ARIA) Beyond the APOE‐ε4 Allele
    Valentinus Besin, Farizky Martriano Humardani, Fenny Lanawati Yudiarto, Paulus Anam Ong, Sulistyo Emantoko Dwi Putra, Ratih Asmana Ningrum
    Chronic Diseases and Translational Medicine 2025
  • Case Studies in Dementia
    Marlee Parsons, Monica Shin, Tharick A. Pascoal, Mira Chamoun, Joseph Therriault, Jean-Paul Soucy, Serge Gauthier, Pedro Rosa-Neto
    2021
  • Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features—An Update
    Stefan Weidauer, Elke Hattingen
    Biomedicines 2025 13 3
  • Clinical Neuroradiology
    Claudia Godi, Andrea Falini
    2019
  • Clinical Performance of Quantitative Susceptibility Mapping in Cerebral Microbleed Detection Relative to 2D GRE
    Sabina Iqbal, Nikita Seth, Tamkin Shahraki, Aristotelis Filippidis, Magdy Selim, Ajith J. Thomas, Yan Wen, Pascal Spincemaille, Yi Wang, Salil Soman
    Clinical Neuroradiology 2025
  • Clinical and neuroimaging precursors in cerebral amyloid angiopathy: impact of the Boston criteria version 2.0
    Stefan Weidauer, Mona Tafreshi, Christian Förch, Elke Hattingen, Christophe T. Arendt, Lucie Friedauer
    European Journal of Neurology 2024 31 10
  • Comparisons of efficacy and safety of immunotherapies for Alzheimer’s disease treatment: a network meta-analysis of randomized controlled trials
    Ching-Hui Su, Ying-Tzu Chang, Huan-Shu Tseng, Chan-Yen Kuo, Jin-Hua Chen, Po- Yu Chien, Yao-Jen Chang, Chin-Chuan Hung
    Clinical Medicine 2025
  • Critical Findings in Neuroradiology
    Marcos Rosa, Renato Hoffmann Nunes, Antônio José da Rocha
    2016
  • Durale und leptomeningeale Erkrankungen: Anatomie, Ursachen und Neurobildgebung
    Ryo Kurokawa, Mariko Kurokawa, Saiko Isshiki, Taisuke Harada, Moto Nakaya, Akira Baba, Shotaro Naganawa, John Kim, Jayapalli R. Bapuraj, Ashok Srinivasan, Osamu Abe, Toshio Moritani
    Neuroradiologie Scan 2025 15 02
  • Imaging Neuroinflammation
    Nivedita Agarwal, Daniel M. Harrison
    2023 9
  • Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know
    R. Alsufayan, C. Hess, T. Krings
    American Journal of Neuroradiology 2023 44 12
  • Monoclonal antibody therapy in Alzheimer’s disease: an overview and vision
    Jonathan H Bentley, Lindsey E Bishop, John I Broussard
    Brain Network and Modulation 2024 3 2
  • Neurobiomarkers: Basic Aspects and Their Relevance in Nonclinical Studies
    Andrea Greiter-Wilke, Nicolau Beckmann, Warren E. Glaab, Diethilde J. Theil, Ingrid D Pardo
    Toxicologic Pathology 2025
  • Radiopaedia.org
    Frank Gaillard, Derek Smith, Arlene Campos
    2011
  • Radiopaedia.org
    Frank Gaillard, Rohit Sharma, Maxime St-Amant
    2016
  • Radiopaedia.org
    Rodrigo Duarte
    2022
  • TRAILBLAZER‐ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease
    Stephen Salloway, Andrew Pain, Elly Lee, Michelle Papka, Margaret B. Ferguson, Hong Wang, Haoyan Hu, Ming Lu, Ena Oru, Paul A. Ardayfio, Deirdre B. Hoban, Emily C. Collins, Dawn A. Brooks, John R. Sims
    Alzheimer's & Dementia 2025 21 5
  • The calcium channel blocker Cav2.1 combined with amyloid beta monoclonal antibodies may reduce the occurrence of ARIA-E
    Dinghao An, Xiaotong Li, Yun Xu
    Medical Hypotheses 2025 196
  • The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center
    Cellas A. Hayes, Christina B. Young, Carla Abdelnour, Alexis Reeves, Michelle C. Odden, Jeffrey Nirschl, Paul K. Crane, Kathleen L. Poston, Elizabeth C. Mormino, Kyan Younes
    Alzheimer's & Dementia 2025 21 3
  • Zerebrale Amyloidangiopathie und ihre Folgen
    Stefan Weidauer
    Radiologie up2date 2024 24 04
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 34 (10)
American Journal of Neuroradiology
Vol. 34, Issue 10
1 Oct 2013
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
MR Imaging Features of Amyloid-Related Imaging Abnormalities
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
J. Barakos, R. Sperling, S. Salloway, C. Jack, A. Gass, J.B. Fiebach, D. Tampieri, D. Melançon, Y. Miaux, G. Rippon, R. Black, Y. Lu, H.R. Brashear, H.M. Arrighi, K.A. Morris, M. Grundman
MR Imaging Features of Amyloid-Related Imaging Abnormalities
American Journal of Neuroradiology Oct 2013, 34 (10) 1958-1965; DOI: 10.3174/ajnr.A3500

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
MR Imaging Features of Amyloid-Related Imaging Abnormalities
J. Barakos, R. Sperling, S. Salloway, C. Jack, A. Gass, J.B. Fiebach, D. Tampieri, D. Melançon, Y. Miaux, G. Rippon, R. Black, Y. Lu, H.R. Brashear, H.M. Arrighi, K.A. Morris, M. Grundman
American Journal of Neuroradiology Oct 2013, 34 (10) 1958-1965; DOI: 10.3174/ajnr.A3500
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
  • Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know
  • Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-{beta}-Amyloid Immunotherapy: A Meta-analysis
  • Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice
  • Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee
  • Tumefactive Primary Central Nervous System Vasculitis: Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease
  • Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis
  • Crossref (86)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
    Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H. Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling, John O’Gorman, Fang Qian, Mahin Arastu, Mingwei Li, Sowmya Chollate, Melanie S. Brennan, Omar Quintero-Monzon, Robert H. Scannevin, H. Moore Arnold, Thomas Engber, Kenneth Rhodes, James Ferrero, Yaming Hang, Alvydas Mikulskis, Jan Grimm, Christoph Hock, Roger M. Nitsch, Alfred Sandrock
    Nature 2016 537 7618
  • Donanemab in Early Symptomatic Alzheimer Disease
    John R. Sims, Jennifer A. Zimmer, Cynthia D. Evans, Ming Lu, Paul Ardayfio, JonDavid Sparks, Alette M. Wessels, Sergey Shcherbinin, Hong Wang, Emel Serap Monkul Nery, Emily C. Collins, Paul Solomon, Stephen Salloway, Liana G. Apostolova, Oskar Hansson, Craig Ritchie, Dawn A. Brooks, Mark Mintun, Daniel M. Skovronsky, Rafael Abreu, Pinky Agarwal, Puja Aggarwal, Marc Agronin, Alison Allen, Dario Altamirano, Gustavo Alva, James Andersen, Allan Anderson, Donald Anderson, Jennifer Arnold, Takashi Asada, Yasuhiro Aso, Vikram Atit, Ricardo Ayala, Michael Badruddoja, Hanna Badzio-jagiello, Michal Bajacek, David Barton, David Bear, Sabrina Benjamin, Richard Bergeron, Perminder Bhatia, Sandra Black, Allan Block, Mohammad Bolouri, Wendy Bond, Jean Bouthillier, Sharon Brangman, Bruce Brew, Sarah Brisbin, Toby Brisken, Amy Brodtmann, Mark Brody, Jared Brosch, Celia Brown, Paul Brownstone, Sylwia Bukowczan, Jeffrey Burns, Alicia Cabrera, Horace Capote, Angel Carrasco, Jose Cevallos Yepez, Eric Chavez, Howard Chertkow, Urszula Chyrchel-paszkiewicz, Anthony Ciabarra, Edward Clemmons, Daniel Cohen, Robert Cohen, Ian Cohen, Mauricio Concha, Brian Costell, Denis Crimmins, Yvette Cruz-pagan, Adolfo Cueli, Robert Cupelo, Maciej Czarnecki, David Darby, P.l.j. Dautzenberg, Peter De Deyn, Jose De La Gandara, Kenneth Deck, David Dibenedetto, Mark Dibuono, Eric Dinnerstein, Ahmet Dirican, Shanker Dixit, Jacek Dobryniewski, Ryan Drake, Peter Drysdale, Ranjan Duara, John Duffy, Aaron Ellenbogen, Victor Faradji, Marc Feinberg, Robert Feldman, Simon Fishman, Stephen Flitman, Concetta Forchetti, Ivonne Fraga, Andrew Frank, Benjamin Frishberg, Hiroto Fujigasaki, Hiroyuki Fukase, Ileana Fumero, Kenichi Furihata, Christopher Galloway, Rekha Gandhi, Kristi George, Marcel Germain, Darren Gitelman, Nicholas Goetsch, Danielle Goldfarb, Mark Goldstein, Lawrence Goldstick, Yaneicy Gonzalez Rojas, Ira Goodman, David Greeley, Carl Griffin, Eric Grigsby, Daniel Grosz, Karl Hafner, David Hart, Sam Henein, Brad Herskowitz, Shinji Higashi, Yasuto Higashi, Gilbert Ho, Jonathan Hodgson, Mark Hohenberg, Larry Hollenbeck, Richard Holub, Tomokatsu Hori, Jakub Hort, Jan Ilkowski, K. Jennifer Ingram, Mitchell Isaac, Mitsunori Ishikawa, Lubos Janu, Mark Johnston, William Julio, William Justiz, Tomotsugu Kaga, Tatsuya Kakigi, Marvin Kalafer, Mikiko Kamijo, Jeffrey Kaplan, Michael Karathanos, Sadao Katayama, Siddharth Kaul, Andrew Keegan, Diana Kerwin, Uzma Khan, Arifulla Khan, Noriyuki Kimura, Gregory Kirk, Gabriela Klodowska, Hisatomo Kowa, Christen Kutz, Joseph Kwentus, Rosalyn Lai, Ayesha Lall, Mary Lawrence, Elly Lee, Ramon Leon, Gary Linker, Pawel Lisewski, Jonathan Liss, Collins Liu, Scott Losk, Ewelina Lukaszyk, Jennifer Lynch, Stephen Macfarlane, Josephine Macsweeney, Nicholas Mannering, Oto Markovic, Donald Marks, Joseph Masdeu, Yutaka Matsui, Kunitaka Matsuishi, Peter Mcallister, Brock Mcconnehey, Alvin Mcelveen, Lora Mcgill, Adam Mecca, Michael Mega, Jason Mensah, Anatol Mickielewicz, Artin Minaeian, Bharat Mocherla, Cynthia Murphy, Paul Murphy, Hirotaka Nagashima, Anil Nair, Malini Nair, John Nardandrea, Marshall Nash, Ziad Nasreddine, Yoshihiko Nishida, Jeffrey Norton, Lazaro Nunez, Jun Ochiai, Takuya Ohkubo, Yasuyuki Okamura, Eugene Okorie, Esteban Olivera, John O'mahony, Omid Omidvar, Desiree Ortiz-Cruz, Alexander Osowa, Michelle Papka, Alicia Parker, Paayal Patel, Ashok Patel, Meenakshi Patel, Claude Patry, Elizabeth Peckham, Michael Pfeffer, Alison Pietras, Michael Plopper, Anton Porsteinsson, Raphael Poulin Robitaille, Niels Prins, Orlando Puente, Marcin Ratajczak, Margaret Rhee, Angela Ritter, Ramon Rodriguez, Lilia Rodriguez Ables, Julio Rojas, Jeffrey Ross, Paule Royer, Jay Rubin, David Russell, Sterre Malou Rutgers, Stephanie Rutrick, Martin Sadowski, Beth Safirstein, Takafumi Sagisaka, Douglas Scharre, Lon Schneider, Curtis Schreiber, Michael Schrift, Paul Schulz, Harvey Schwartz, Julie Schwartzbard, John Scott, Lissette Selem, Pramod Sethi, Sharon Sha, Kenneth Sharlin, Sanjiv Sharma, Thomas Shiovitz, Rajinder Shiwach, Martin Sladek, Bart Sloan, Amanda Smith, Paul Solomon, Ehab Sorial, Evelio Sosa, Mary Stedman, Susan Steen, Lee Stein, Arkadiy Stolyar, John Stoukides, Shinji Sudoh, James Sutton, Junaid Syed, Kinga Szigeti, Hisatsugu Tachibana, Yuichi Takahashi, Amane Tateno, James Dale Taylor, Kelly Taylor, Oleg Tcheremissine, Adly Thebaud, Stephen Thein, Louise Thurman, Steven Toenjes, Hiromasa Toji, Misaki Toma, Duc Tran, Pilar Trueba, Masashi Tsujimoto, Raymond Turner, Akiyoshi Uchiyama, Dorota Ussorowska, Sanjeev Vaishnavi, Elena Valor, Joel Vandersluis, Alberto Vasquez, Juan Velez, Cherian Verghese, Klaudia Vodickova-borzova, David Watson, David Weidman, David Weisman, Alexander White, Katherine Willingham, Izabela Winkel, Paul Winner, Jaron Winston, Adam Wolff, Hideo Yagi, Hideki Yamamoto, Sanjay Yathiraj, Yasumasa Yoshiyama, Marzena Zboch
    JAMA 2023 330 6
  • Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
    Stephen Salloway, Spyros Chalkias, Frederik Barkhof, Patrick Burkett, Jerome Barakos, Derk Purcell, Joyce Suhy, Fiona Forrestal, Ying Tian, Kimberly Umans, Guanfang Wang, Priya Singhal, Samantha Budd Haeberlein, Karen Smirnakis
    JAMA Neurology 2022 79 1
  • Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
    Harald Hampel, Aya Elhage, Min Cho, Liana G Apostolova, James A R Nicoll, Alireza Atri
    Brain 2023 146 11
  • Anti-amyloid antibody therapies in Alzheimer’s disease
    Robert Perneczky, Frank Jessen, Timo Grimmer, Johannes Levin, Agnes Flöel, Oliver Peters, Lutz Froelich
    Brain 2023 146 3
  • Amyloid-Related Imaging Abnormalities and β-Amyloid–Targeting Antibodies
    Massimo Filippi, Giordano Cecchetti, Edoardo Gioele Spinelli, Paolo Vezzulli, Andrea Falini, Federica Agosta
    JAMA Neurology 2022 79 3
  • Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
    Charles G. Withington, R. Scott Turner
    Frontiers in Neurology 2022 13
  • Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
    Ana-María Lacosta, María Pascual-Lucas, Pedro Pesini, Diego Casabona, Virginia Pérez-Grijalba, Iván Marcos-Campos, Leticia Sarasa, Jesus Canudas, Hassnae Badi, Inmaculada Monleón, Itziar San-José, Josep Munuera, Octavio Rodríguez-Gómez, Carla Abdelnour, Asunción Lafuente, Mar Buendía, Mercè Boada, Lluis Tárraga, Agustín Ruiz, Manuel Sarasa
    Alzheimer's Research & Therapy 2018 10 1
  • Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice
    P.M. Cogswell, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.R. Jack, T.Y. Poussaint, C.A. Raji, V.K. Ramanan, C.T. Whitlow
    American Journal of Neuroradiology 2022 43 9
  • Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives
    Mina Park, Won-Jin Moon
    Korean Journal of Radiology 2016 17 6

More in this TOC Section

  • Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis
  • SWI or T2*: Which MRI Sequence to Use in the Detection of Cerebral Microbleeds? The Karolinska Imaging Dementia Study
  • Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study
Show more BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire